Clinical Trials Directory

Trials / Completed

CompletedNCT01958619

Open Label Pharmacokinetic Study of OZ439 and Piperaquine on Administration of OZ439+TPGS Granules for Oral Suspension Alone or With Either Piperaquine Phosphate Tablets or Granules for Oral Solution in Healthy Volunteers

Open Label Pharmacokinetic Study of OZ439 and Piperaquine Following Administration of OZ439+TPGS Granules for Oral Suspension Alone or With Either Piperaquine Phosphate Tablets or Granules for Oral Solution in the Fasted State in Healthy Volunteers

Status
Completed
Phase
Phase 1
Study type
Interventional
Enrollment
55 (actual)
Sponsor
Medicines for Malaria Venture · Academic / Other
Sex
All
Age
18 Years – 55 Years
Healthy volunteers
Accepted

Summary

A healthy volunteer study to characterise the exposure of the two study medications, following administration of OZ439 + TPGS granules with piperaquine phosphate granules (intended for children) and with piperaquine phosphate tablets (intended for adults). Ideally, to confirm the exposure demonstrated in an earlier bioavailability study.

Detailed description

A Phase 1 open label parallel group, four arm study conducted in healthy male and female subject aged 18 to 55 years of age. Subjects will receive either treatment A, B, C or D as described below: * Treatment A: 1440 mg PQP tablets and 800 mg OZ439 + TPGS granules for oral suspension * Treatment B: 960 mg PQP tablets and 800 mg OZ439 + TPGS granules for oral suspension * Treatment C: 960 mg PQP granules for oral solution and 800 mg OZ439 + TPGS granules for oral suspension * Treatment D: 800 mg OZ439 + TPGS granules for oral suspension

Conditions

Interventions

TypeNameDescription
DRUG1440mg PQP tabletsPiperaquine phosphate tablets (1440mg)
DRUG960mg PQP tabletsPiperaquine phosphate tablets (960mg)
DRUG800mg OZ439 + TPGSOZ439 (800mg) + TPGS granules for oral suspension
DRUG960mg PQP granulesPiperaquine phosphate granules for oral solution (960mg)

Timeline

Start date
2013-10-01
Primary completion
2014-01-01
Completion
2014-01-01
First posted
2013-10-09
Last updated
2015-05-08
Results posted
2015-04-21

Locations

1 site across 1 country: United Kingdom

Source: ClinicalTrials.gov record NCT01958619. Inclusion in this directory is not an endorsement.

Open Label Pharmacokinetic Study of OZ439 and Piperaquine on Administration of OZ439+TPGS Granules for Oral Suspension A (NCT01958619) · Clinical Trials Directory